ZBRA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Zebra Technologies Corp (ZBRA) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has positive industrial trends and partnerships, its declining financial performance, overbought technical indicators, and lack of strong proprietary trading signals suggest waiting for a better entry point.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI of 84.54 suggests the stock is overbought, and the current price is near resistance levels (R2: 239.115). Converging moving averages indicate potential consolidation. Stock trend analysis shows a high probability of slight declines in the short term.
Hedge funds are significantly increasing their holdings.
Partnerships with Aiva Health to enhance healthcare efficiency using AI-driven technology.
Acquisition of Zebra's Robotics Automation business by Skild AI, focusing on high-growth sectors.
Financial performance in Q4 2025 showed a significant decline in net income (-57.06% YoY) and EPS (-56.05% YoY).
Analysts have been lowering price targets, with Citi and Baird reducing their targets recently.
Overbought technical indicators suggest limited short-term upside.
In Q4 2025, revenue grew by 10.57% YoY to $1.475 billion, but net income dropped significantly by 57.06% YoY to $70 million. EPS also declined by 56.05% YoY to 1.38, and gross margin fell to 44.61%, down 4.64% YoY. This indicates revenue growth is not translating into profitability.
Analysts are mixed on ZBRA. Some, like UBS and Barclays, maintain positive ratings with price targets above $300, citing long-term growth potential. However, Citi and Baird have recently lowered their price targets, reflecting cautious sentiment. The consensus suggests gradual improvement in industrial trends but highlights near-term challenges.
